EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Functional Peptide-Loaded Gelatin Nanoparticles as Eyedrops for Cornea Neovascularization Treatment

Ya-Chun Chu, Hsu-Wei Fang, Yu-Yi Wu, Yu-Jun Tang, Erh-Hsuan Hsieh, YiZhou She, Che-Yi Chang, I-Chan Lin, Yin-Ju Chen, Guei-Sheung Liu iD, Ching-Li Tseng iD

International Journal of Nanomedicine · 2023-03 · Volume 18 · 1413-1431

DOI: 10.2147/ijn.s398769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2023-03. Verfasst von Ya-Chun Chu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei City, Taiwan. Hauptthemen laut MEDLINE: Corneal Neovascularization, Nanoparticles. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Corneal neovascularization (NV) is a process of abnormal vessel growth into the transparent cornea from the limbus and can disturb the light passing through the cornea, resulting in vision loss or even blindness. The use of nanomedicine as an effective therapeutic formulation in ophthalmology has led to higher drug bioavailability and a slow drug release rate. In this research, we designed and explored the feasibility of a new nanomedicine, gp91 ds-tat (gp91) peptide-encapsulated gelatin nanoparticles (GNP-gp91), for inhibiting corneal angiogenesis.

Methods

GNP-gp91 were prepared by a two-step desolvation method. The characterization and cytocompatibility of GNP-gp91 were analyzed. The inhibition effect of GNP-gp91 on HUVEC cell migration and tube formation was observed by an inverted microscope. The drug retention test in mouse cornea was observed by in vivo imaging system, fluorescence microscope, and DAPI/TAMRA staining. Finally, the therapeutic efficacy and evaluation of neovascularization-related factors were conducted through the in vivo corneal NV mice model via topical delivery.

Results

The prepared GNP-gp91 had a nano-scale diameter (550.6 nm) with positive charge (21.7 mV) slow-release behavior (25%, 240hr). In vitro test revealed that GNP-gp91 enhanced the inhibition of cell migration and tube formation capacity via higher internalization of HUVEC. Topical administration (eyedrops) of the GNP-gp91 significantly prolongs the retention time (46%, 20 min) in the mouse cornea. In chemically burned corneal neovascularization models, corneal vessel area with a significant reduction in GNP-gp91 group (7.89%) was revealed when compared with PBS (33.99%) and gp91 (19.67%) treated groups via every two days dosing. Moreover, GNP-gp91 significantly reduced the concentration of Nox2, VEGF and MMP9 in NV's cornea.

Conclusion

The nanomedicine, GNP-gp91, was successfully synthesized for ophthalmological application. These data suggest that GNP-gp91 contained eyedrops that not only have a longer retention time on the cornea but also can treat mice corneal NV effectively delivered in a low dosing frequency, GNP-gp91 eyedrops provides an alternative strategy for clinical ocular disease treatment in the culture.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Corneal NeovascularizationNanoparticlesMiceAnimalsGelatinOphthalmic SolutionsCorneaPeptides

Stichwörter der Autor:innen

control releasecorneal neovascularizationeye dropsgelatingp91 peptidenanoparticlesocular retention

Substanzen

GelatinOphthalmic SolutionsPeptides

Autor:innen und Institutionen

  • Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei City, Taiwan.
  • Department of Chemical Engineering and Biotechnology, National Taipei University of Technology, Taipei City, Taiwan.
  • Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli County, Taiwan.
  • School of Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei City, Taiwan.
  • Department of Ophthalmology, Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan.
  • Department of Ophthalmology, School of Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan.

ORCID-Profile: Guei-Sheung Liu, Ching-Li Tseng

Zitieren

APA

Chu, Y. C., Fang, H. W., Wu, Y. Y., Tang, Y. J., Hsieh, E. H., She, Y., Chang, C. Y., Lin, I. C., Chen, Y. J., Liu, G. S., & Tseng, C. L. (2023). Functional Peptide-Loaded Gelatin Nanoparticles as Eyedrops for Cornea Neovascularization Treatment. International Journal of Nanomedicine, Volume 18, 1413-1431. https://doi.org/10.2147/ijn.s398769

Vancouver

Chu YC, Fang HW, Wu YY, Tang YJ, Hsieh EH, She Y, et al. Functional Peptide-Loaded Gelatin Nanoparticles as Eyedrops for Cornea Neovascularization Treatment. International Journal of Nanomedicine. 2023;Volume 18:1413-1431. doi:10.2147/ijn.s398769

BibTeX
@article{Chu2023,
  author = {Chu, Ya-Chun and Fang, Hsu-Wei and Wu, Yu-Yi and Tang, Yu-Jun and Hsieh, Erh-Hsuan and She, YiZhou and Chang, Che-Yi and Lin, I-Chan and Chen, Yin-Ju and Liu, Guei-Sheung and Tseng, Ching-Li},
  title = {Functional Peptide-Loaded Gelatin Nanoparticles as Eyedrops for Cornea Neovascularization Treatment},
  journal = {International Journal of Nanomedicine},
  year = {2023},
  volume = {Volume 18},
  pages = {1413--1431},
  doi = {10.2147/ijn.s398769}
}
Kostenlos starten →